• FDA Meeting – Qnexa Safety and Efficacy
    Statement of Kate Ryan Food and Drug Administration’s (FDA) Endocrinologic and Metabolic Drugs Advisory Committee Meeting The National Women’s Health Network is a nonprofit advocacy organization that works to improve the health of all women. We bring the voices of women consumers to policy and regulatory decision-making bodies. We are supported by our members and do not take financial contributions from ...
  • FDA Meeting – Naltrexone/Bupropion (Contrave)
    Statement of Kate Ryan, Program Coordinator Food and Drug Administration (FDA) Gastroenterology Endocrinologic and Metabolic Drugs Advisory Committee The National Women’s Health Network is a nonprofit advocacy organization that works to improve the health of all women. We bring the voices of women consumers to the policy and regulatory decisionmaking bodies. We are supported by our members and ...